PHASE-I TRIAL OF ESCALATING DOSES OF CISPLATIN IN HYPERTONIC SALINE

被引：34

作者：

BAJORIN, D ^{[1
]}

BOSL, GJ ^{[1
]}

FEIN, R ^{[1
]}

机构：

[1] CORNELL UNIV,MED CTR,COLL MED,DEPT MED,NEW YORK,NY 10021

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 10期

关键词：

D O I：

10.1200/JCO.1987.5.10.1589

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1589 / 1593

页数：5

共 23 条

[1]

BAJORIN DF, 1986, CANCER RES, V46, P5969

[2] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

JONES, AC ;

MCELWAIN, TJ ;

RAJU, S ;

WILTSHAW, E ;

SMITH, IE ;

BAKER, JM ;

PECKHAM, MJ ;

HARRAP, KR .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147

[3] CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN [J].

CORDEN, BJ ;

FINE, RL ;

OZOLS, RF ;

COLLINS, JM .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) :38-41

[4] A STUDY OF THE PROTECTIVE EFFECT OF CHLORIDE SALTS ON CISPLATIN NEPHROTOXICITY [J].

DALEYYATES, PT ;

MCBRIEN, DCH .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (13) :2363-2369

[5] CISPLATIN METABOLITES IN PLASMA, A STUDY OF THEIR PHARMACOKINETICS AND IMPORTANCE IN THE NEPHROTOXIC AND ANTITUMOUR ACTIVITY OF CISPLATIN [J].

DALEYYATES, PT ;

MCBRIEN, DCH .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (19) :3063-3070

[6]

EARHART RH, 1983, CANCER RES, V43, P1187

[7]

FORESTIERE AA, 1982, AM J CLIN ONCOL-CANC, V5, P243

[8]

GANDARA DR, 1986, CANCER TREAT REP, V70, P820

[9] CISPLATIN AND VINDESINE COMBINATION CHEMOTHERAPY FOR ADVANCED-CARCINOMA OF THE LUNG - A RANDOMIZED TRIAL INVESTIGATING 2 DOSAGE SCHEDULES [J].

GRALLA, RJ ;

CASPER, ES ;

KELSEN, DP ;

BRAUN, DW ;

DUKEMAN, ME ;

MARTINI, N ;

YOUNG, CW ;

GOLBEY, RB .

ANNALS OF INTERNAL MEDICINE, 1981, 95 (04) :414-420

[10]

HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO

← 1 2 3 →